Log in

OTCMKTS:VEGPFVectura Group Stock Price, Forecast & News

$1.22
0.00 (0.00 %)
(As of 07/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.22
Now: $1.22
$1.22
50-Day Range
$0.80
MA: $0.92
$1.22
52-Week Range
$0.80
Now: $1.22
$1.22
VolumeN/A
Average VolumeN/A
Market Capitalization$737.20 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Vectura Group plc engages in the design, development, and supply of pharmaceutical products for the treatment of airways-related diseases worldwide. The company's in-market products include Seebri Breezhaler and Neohaler, a DPI device and bronchodilator; AirFluSal Forspiro for the treatment of asthma and chronic obstructive pulmonary disease (COPD); Breelib for the treatment of pulmonary arterial hypertension; Relvar Ellipta/Breo Ellipta that is used in treating asthma and COPD; and Incruse Ellipta and Anoro Ellipta for the treatment of COPD. Its generic partnering products include flutiform, VR315, VR506, VR730, VR632, VR2081, VR410, and Ellipta for the treatment of asthma; and Phase I clinical stage product is the VR475 (US) for the treatment of severe adult asthma. The company's Phase II clinical stage products comprise VR465 for treating respiratory syncytial virus infection; VR647 for the treatment of paediatric asthma; and VR736 for the treatment severe influenza. Its Phase III clinical stage products include QVM149 for the treatment of asthma; and VR475 (EU) for the treatment of severe adult asthma. The company also provides dry powder inhalers; pressurized meter dose inhalers; and smart nebulizers. Vectura Group plc was founded in 1997 and is headquartered in Chippenham, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.84 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:VEGPF
CUSIPN/A
CIKN/A
Phone44-0-12-4966-7700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$227.68 million
Book Value$0.89 per share

Profitability

Miscellaneous

Employees478
Market Cap$737.20 million
Next Earnings DateN/A
OptionableNot Optionable

Receive VEGPF News and Ratings via Email

Sign-up to receive the latest news and ratings for VEGPF and its competitors with MarketBeat's FREE daily newsletter.

Vectura Group (OTCMKTS:VEGPF) Frequently Asked Questions

How has Vectura Group's stock been impacted by COVID-19 (Coronavirus)?

Vectura Group's stock was trading at $1.12 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, VEGPF shares have increased by 8.9% and is now trading at $1.22. View which stocks have been most impacted by Coronavirus.

Has Vectura Group been receiving favorable news coverage?

News stories about VEGPF stock have trended very negative recently, according to InfoTrie. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Vectura Group earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news about Vectura Group.

Who are some of Vectura Group's key competitors?

Who are Vectura Group's key executives?

Vectura Group's management team includes the following people:
  • Mr. James Ward-Lilley, CEO & Exec. Director (Age 54)
  • Mr. Paul Fry, CFO & Exec. Director
  • Mr. Anthony Fitzpatrick, Exec. VP of Operations
  • Elizabeth Knowles, VP of Investor Relations
  • Mr. John Murphy, Gen. Counsel & Company Sec. (Age 66)

What is Vectura Group's stock symbol?

Vectura Group trades on the OTCMKTS under the ticker symbol "VEGPF."

How do I buy shares of Vectura Group?

Shares of VEGPF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Vectura Group's stock price today?

One share of VEGPF stock can currently be purchased for approximately $1.22.

How big of a company is Vectura Group?

Vectura Group has a market capitalization of $737.20 million and generates $227.68 million in revenue each year. The company earns $-28,220,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis. Vectura Group employs 478 workers across the globe.

What is Vectura Group's official website?

The official website for Vectura Group is www.vectura.com.

How can I contact Vectura Group?

Vectura Group's mailing address is One Prospect West, Wiltshire X0, SN14 6FH. The company can be reached via phone at 44-0-12-4966-7700 or via email at [email protected]

This page was last updated on 7/2/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.